A detailed history of Hemenway Trust CO LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hemenway Trust CO LLC holds 17,707 shares of LLY stock, worth $18.1 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
17,707
Previous 11,955 48.11%
Holding current value
$18.1 Million
Previous $9.32 Million 44.97%
% of portfolio
1.09%
Previous 0.77%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$625.65 - $812.69 $3.6 Million - $4.67 Million
5,752 Added 48.11%
17,707 $13.5 Million
Q2 2025

Jul 23, 2025

BUY
$713.71 - $898.95 $4.47 Million - $5.64 Million
6,270 Added 110.29%
11,955 $9.32 Million
Q1 2025

Apr 18, 2025

BUY
$725.72 - $929.72 $4.13 Million - $5.29 Million
5,685 New
5,685 $4.7 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hemenway Trust CO LLC Portfolio

Follow Hemenway Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemenway Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hemenway Trust CO LLC with notifications on news.